Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents
Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior
About this trial
This is an interventional prevention trial for Vaccine-Preventable Diseases focused on measuring COVID-19 Vaccine, Digital storytelling, Hispanic children, Vaccine hesitancy, Health disparities
Eligibility Criteria
Inclusion Criteria: self-identifies as Hispanic is a biological parent or a legal guardian of at least one child under 18 years old their child(ren) are not vaccinated against up-to-date with COVID-19 vaccine doses agrees to send and receive a text message and submit a photo of their child's immunization record for T3 data collection. Exclusion Criteria: individuals who do not meet inclusion criteria or are unable/ unwilling to provide consent.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Baseline and Digital Storytelling (DST)
Baseline and Control
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).